American Society of Hirudotherapy

Development and validation of interpretable machine learning models for predicting the risk of necrosis after finger replantation: A retrospective multicenter study

Research article published in Injury (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studySafety & Infection ControlDong et al. · Injury, 2025

Abstract

INTRODUCTION: Digital necrosis (DN) is a critical postoperative complication following finger replantation surgery. This can necessitate additional surgical interventions that can adversely affect the patient's hand functionality, psychological well-being, and financial standing. The timely identification and management of the risk of post-replantation DN are thus crucial for enhancing patient outcomes. The objective of this study was to create and validate an easily understandable machine learning (ML) model for predicting the risk of DN following finger replantation surgery. PATIENTS AND METHODS: Data from 1579 patients who underwent finger replantation surgery at Suzhou Ruihua Orthopaedic Hospital between September 2018 and September 2023 were collected and divided into training and internal validation sets. Additionally, 293 data points from two other institutions were employed as independent external validation sets. Ten machine-learning methods, including Gradient Boosting Machine (GBM), were utilized for modeling. The performance of the model was assessed using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA). SHapley Additive exPlanation (SHAP) was utilized to provide both global and local interpretations of the final model. RESULTS: Nine indices, including the seniority of the doctor and the neutrophil count, were identified as independent predictors of DN. The GBM model showed optimal model with high predictive accuracy for DN risk in both the training set (AUC: 0.995) and the internal validation set (AUC: 0.978), which was confirmed using external validation (AUC: 0.983). The reliability and utility of the GBM model and the web-based computing platform were confirmed by DCA, calibration curve, accuracy, and sensitivity analyses. CONCLUSION: An interpretable machine-learning model based on complete blood counts and related inflammatory marker levels was constructed and validated to predict the likelihood of developing DN following finger replantation. This model can assist clinicians in the prompt identification of high-risk patients post-replantation, enabling timely intervention.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleMulticenter StudyValidation Study
Indexed MeSH termsHumansMachine LearningRetrospective StudiesReplantationMaleFemaleAdultFinger InjuriesNecrosisMiddle AgedPostoperative ComplicationsRisk Assessment

Summary

Peer-reviewed research on safety and infection-control considerations relevant to leech therapy and anticoagulation. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This retrospective multicenter study developed and validated interpretable machine-learning models to predict digital necrosis (DN) after finger replantation, using 1,579 patients for training/internal validation and 293 external cases from two other institutions; a Gradient Boosting Machine using complete-blood-count and inflammatory markers reached high discrimination (AUC about 0.995 training, 0.978 internal, 0.983 external), with nine predictors including the seniority of the doctor and neutrophil count. It is relevant to hirudotherapy because digital necrosis from venous congestion is the precise failure mode that leech therapy is used to prevent in compromised replants, so a validated tool that flags high-risk digits could help target timely interventions, including adjunctive measures, before a replant is lost. Honest caveat: this is a retrospective prediction-modeling study; it does not evaluate leech therapy, and the very high reported AUCs require prospective and broader external validation before clinical reliance.

Citation

Development and validation of interpretable machine learning models for predicting the risk of necrosis after finger replantation: A retrospective multicenter study.

Dong et al. · Injury, 2025

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.